Evotec AG of Hamburg, Germany, has
sold the core of its single-molecule detection technology and has transferred or
licensed the corresponding intellectual property portfolio to Olympus Corp. of Tokyo.
This segment of Evotec’s business generated approximately €2.5 million in
2005. Evotec expects up to 5 percent revenue growth from its remaining business
and has factored the net financial gains from this deal into its latest report to
MORE FROM PHOTONICS MEDIA